| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/05/2006 | CA2571419A1 A preparation comprising batroxobin for inhibiting local invasion of malignant tumors |
| 01/05/2006 | CA2571415A1 Pharmaceutical composition comprising botulinum toxin for treating knee joint pain by saphenous nerve entrapment |
| 01/05/2006 | CA2571341A1 Method of complexing a protein by the use of a dispersed system and proteins thereof |
| 01/05/2006 | CA2571315A1 Ccr ligands for stem cell homing |
| 01/05/2006 | CA2567470A1 Prouroguanylin as therapeutic and diagnostic agents |
| 01/05/2006 | CA2566991A1 Malignant tumor-inhibiting preparation comprising des a fibrin |
| 01/05/2006 | CA2560631A1 Improved inhibitor nucleic acids |
| 01/05/2006 | CA2549830A1 Selective incorporation of 5-hyroxytryptophan into proteins in mammalian cells |
| 01/05/2006 | CA2544676A1 Use of peptides derived from the a alpha or b beta chain of human fibrinogen for the treatment of shock |
| 01/04/2006 | EP1612555A1 Cryptic peptides for use in inducing immunologic tolerance |
| 01/04/2006 | EP1612272A2 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 01/04/2006 | EP1612268A1 Receptor ligand VEGF-C |
| 01/04/2006 | EP1612223A2 Polypeptides with FC binding ability |
| 01/04/2006 | EP1612222A2 Olfactory and pheromones G-protein coupled receptors |
| 01/04/2006 | EP1612219A1 Allergen from house-dust mites |
| 01/04/2006 | EP1612215A1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/04/2006 | EP1611900A1 Method of treating inflammtory disease associated with bone destruction |
| 01/04/2006 | EP1611899A1 Combined use of g-csf with angiogenetic factor |
| 01/04/2006 | EP1611898A1 Composition for the prevention and treatment of cellulitis |
| 01/04/2006 | EP1611897A2 Whole or disrupted insect cells as adjuvant for antigens |
| 01/04/2006 | EP1611885A1 Use of an inducing agent for the treatment of blood, viral and cellular disorders |
| 01/04/2006 | EP1611239A1 Cyclic amp response element activator proteins and uses related thereto |
| 01/04/2006 | EP1611236A1 Method for the production of gla-residue containing serine proteases |
| 01/04/2006 | EP1611233A2 Stem cells having increased sensitivity to sdf-1 and methods of generating and using same |
| 01/04/2006 | EP1611231A2 Rna interference compositions and methods |
| 01/04/2006 | EP1611173A1 Polymeric modifiers and pharmaceutical compositions |
| 01/04/2006 | EP1611153A2 Antitumor effect of mutant bik |
| 01/04/2006 | EP1611151A2 Stq-peptides |
| 01/04/2006 | EP1611093A2 Modified transferrin fusion proteins |
| 01/04/2006 | EP1610824A2 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer |
| 01/04/2006 | EP1610822A1 Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant |
| 01/04/2006 | EP1610818A1 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 01/04/2006 | EP1610814A1 Therapeutic composition for autoimmune conditions |
| 01/04/2006 | EP1610813A1 CONFORMATIONALLY CONSTRAINED PARATHYROID HORMONES WITH a-HELIX STABILIZERS |
| 01/04/2006 | EP1610812A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 01/04/2006 | EP1610811A2 Prevention and treatment of cardiac arrhythmias |
| 01/04/2006 | EP1610810A2 Use of clusterin for the treatment and/or prevention of peripheral neurological diseases |
| 01/04/2006 | EP1610809A2 Vault and vault-like carrier molecules |
| 01/04/2006 | EP1610808A2 Covalent attachment of ligands to nucleophilic proteins guided by non-covalent binding |
| 01/04/2006 | EP1610806A2 Method of treating cancer with azaspirane compositions |
| 01/04/2006 | EP1610805A2 Thiol-mediated drug attachment to targeting peptides |
| 01/04/2006 | EP1610804A2 Igf-binding protein-derived peptide or small molecule |
| 01/04/2006 | EP1610803A2 Methods and kits for maintaining pregnancy, treating follicular cysts, and synchronizing ovulation using luteinizing hormone |
| 01/04/2006 | EP1610802A2 Parkin interacting polypeptides and methods of use |
| 01/04/2006 | EP1610800A2 Methods and compositions for increasing the anaerobic working capacity in tissues |
| 01/04/2006 | EP1610765A2 Non-aqueous single phase vehicles and formulations utilizing such vehicles |
| 01/04/2006 | EP1610760A2 Topical l-carnitine compositions |
| 01/04/2006 | EP1610752A2 Localized drug delivery using drug-loaded nanocapsules and implantable device coated with the same |
| 01/04/2006 | EP1610674A2 Methods of administering a material into a patient for dermal enhancement |
| 01/04/2006 | EP1534744A4 Altered insulin-like growth factor binding proteins |
| 01/04/2006 | EP1474516A4 Methods of modulating cold sensory perception |
| 01/04/2006 | EP1469811A4 Methods and compositions for oxygen transport comprising modified hemoglobin in plasma |
| 01/04/2006 | EP1397153A4 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 01/04/2006 | EP1311677B1 Regulation of human p2y1-like g protein-coupled receptor |
| 01/04/2006 | EP1294390B1 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotection from glutamate toxicity |
| 01/04/2006 | EP1250422B1 Myeloid colony stimulating factor and uses thereof |
| 01/04/2006 | EP1223950B1 Ribozyme therapy for the treatment of proliferative eye diseases |
| 01/04/2006 | EP1202744B1 PRODUCTION OF rhPBGD |
| 01/04/2006 | EP1178834B1 Controlled release of growth factors from heparin containing matrices |
| 01/04/2006 | EP1169298B1 Pharmaceutical compounds |
| 01/04/2006 | EP1150995B1 A synthetic peptide disturbing intracellular signaling |
| 01/04/2006 | EP1146881B1 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin |
| 01/04/2006 | EP1128844B1 Botulinum toxins for enhancing wound healing |
| 01/04/2006 | EP1077728B1 Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy |
| 01/04/2006 | EP1070083B1 Crystalline forms of 1s- [1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9- [[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino [1, 2-a][ 1,2] diazepine-1-carboxamide |
| 01/04/2006 | EP1053325B1 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
| 01/04/2006 | EP1044008B1 Use of aliphatic polyamines for reducing oxalate |
| 01/04/2006 | EP1019518B1 Self-deleting vectors for cancer therapy |
| 01/04/2006 | EP0970243B1 Diagnosis and treatment of glaucoma |
| 01/04/2006 | EP0923606B1 Antigenic fusionprotein carrying galalpha1,3gal epitopes |
| 01/04/2006 | EP0804609B1 NOVEL p53 RESPONSE GENES |
| 01/04/2006 | CN1717587A Methods of protecting against radiation damage using alpha thymosin |
| 01/04/2006 | CN1717417A Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases |
| 01/04/2006 | CN1717415A Peptide gap junction modulators |
| 01/04/2006 | CN1717249A Prekallikrein depleted plasma derived albumin fraction |
| 01/04/2006 | CN1717248A Combined tumor treating method by heat shock protein tumor internal administration and cytotoxin agent |
| 01/04/2006 | CN1715926A Neuregulin mutant, screening method and use |
| 01/04/2006 | CN1715409A Process for preparing medicine grade recombined human urine trypase inhibitor |
| 01/04/2006 | CN1715402A Biological enzyme activator |
| 01/04/2006 | CN1715296A Recombinant human mannan-binding lectin |
| 01/04/2006 | CN1715293A Ganoderma tsugae-proteoglycan mixture and its preparing method and use |
| 01/04/2006 | CN1714864A Nano grade polypeptide anti-dental caries material and producing method and tooth-paste containing said material |
| 01/04/2006 | CN1714863A Method for extracting curcin and its use |
| 01/04/2006 | CN1714862A Liver cancer relative gene DLK1 and its use |
| 01/04/2006 | CN1714861A Thymus penta peptide slow releasing micro ball and its preparing method |
| 01/04/2006 | CN1234853C Production method of corn super oxide dismutase multi-enzyme |
| 01/04/2006 | CN1234731C Human erythropoietin Fc fusion protein with high bioactivity |
| 01/04/2006 | CN1234728C Novel human lymphokine, its coding sequence and use |
| 01/04/2006 | CN1234727C Human thymosin alpha protogene mutant synthesis, expression and use |
| 01/04/2006 | CN1234411C Anti-tumor medicine |
| 01/04/2006 | CN1234410C Brain protein hydrolysate freeze-drying powder injection and its preparing method |
| 01/04/2006 | CN1234344C Inhalation composition |
| 01/03/2006 | US6982361 Method of screening a compound for anxiolytic activity in an Apolipoprotein e knockout animal |
| 01/03/2006 | US6982326 Allergenic proteins and peptides from Japanese cedar pollen |
| 01/03/2006 | US6982323 Chimeric proteins for diagnosis and treatment of diabetes |
| 01/03/2006 | US6982320 Cytokine receptor common gamma chain like |
| 01/03/2006 | US6982319 Protein for use in the treatment of liver disorders, fibrosis, cancer, rheumatoid arthritis and glomeronephritis |
| 01/03/2006 | US6982316 Isolated nucleic acid molecules associated with colon cancer and methods for diagnosing and treating colon cancer |
| 01/03/2006 | US6982314 Lawsonia intracellularis proteins, and related methods and materials |
| 01/03/2006 | US6982250 Methods of prevention and treatment of inflammatory bowel disease |